Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-061048

EVP, CFO & CBO sold 125,000 shares at $125.50 ($15,687,500)

  • EVP, CFO & CBO acquired 125,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Mahatme Sandesh · EVP, CFO & CBO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2019-12-13 Exercise or conversion : show line 1 in the form +4,319 $13.71 $59,213 34,498 D
2019-12-13 Exercise or conversion : show line 2 in the form +4,138 $13.71 $56,732 38,636 D
2019-12-13 Exercise or conversion : show line 3 in the form +10,466 $23.85 $249,614 49,102 D
2019-12-13 Exercise or conversion : show line 4 in the form +69,479 $29.03 $2,016,975 118,581 D
2019-12-13 Exercise or conversion : show line 5 in the form +21,875 $32.63 $713,781 140,456 D
2019-12-13 Exercise or conversion : show line 6 in the form +14,723 $34.92 $514,127 155,179 D
2019-12-13 Sale : show line 7 in the form −125,000 $125.50 $15,687,500 30,179 D
Open-market sales · 125,000 sh · avg $125.50 · $15,687,500

Table II: Derivative

6 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-12-13 Exercise or conversion : show line 8 in the form Stock option (right to buy) −4,319 $13.71 2026-02-28 4,319 3,085 D
2019-12-13 Exercise or conversion : show line 9 in the form Stock option (right to buy) −4,138 $13.71 2026-02-28 4,138 2,633 D
2019-12-13 Exercise or conversion : show line 10 in the form Stock option (right to buy) −10,466 $23.85 2022-11-05 10,466 0 D
2019-12-13 Exercise or conversion : show line 11 in the form Stock option (right to buy) −69,479 $29.03 2024-02-28 69,479 0 D
2019-12-13 Exercise or conversion : show line 12 in the form Stock option (right to buy) −21,875 $32.63 2027-03-10 21,875 10,874 D
2019-12-13 Exercise or conversion : show line 13 in the form Stock option (right to buy) −14,723 $34.92 2023-06-04 14,723 39,277 D
Loading xslF345X03/doc4.xml…